Advertisement
Canada markets closed

  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • CAD/USD

    0.7319
    -0.0002 (-0.02%)
     

  • CRUDE OIL

    83.45
    +0.09 (+0.11%)
     

  • Bitcoin CAD

    91,005.94
    -253.42 (-0.28%)
     

  • CMC Crypto 200

    1,429.26
    +14.50 (+1.02%)
     

  • GOLD FUTURES

    2,337.10
    -5.00 (-0.21%)
     

  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     

  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     

  • NASDAQ futures

    17,701.00
    +94.25 (+0.54%)
     

  • VOLATILITY

    15.69
    -1.25 (-7.38%)
     

  • FTSE

    8,044.81
    +20.94 (+0.26%)
     

  • NIKKEI 225

    37,552.16
    0.00 (0.00%)
     

  • CAD/EUR

    0.6837
    +0.0001 (+0.01%)
     

Medivation (MDVN) Jumps: Stock Adds 7.5% in Session

Zacks Equity Research

Medivation, Inc. (MDVN) was a big mover last session, as its shares rose nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $69.58 to $77.83 in the past one-month timeframe.

In the last 30 days, the company witnessed a mixed track record of three positive and two negative estimate revisions. Meanwhile, the Zacks Consensus Estimate moved higher suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if Friday’s jump can turn into more strength down the road.

Medivation currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Other better-ranked stocks in the med-drugs industry include Actelion Ltd. (ALIOF), Cambrex Corporation. (CBM) and Curis, Inc. (CRIS). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



MEDIVATION INC (MDVN): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report

CAMBREX CORP (CBM): Free Stock Analysis Report

CURIS INC (CRIS): Free Stock Analysis Report


Zacks Investment Research